Effects of the dietary supplements, activated charcoal and copper chlorophyllin, on urinary excretion of trimethylamine in Japanese trimethylaminuria patients

被引:51
作者
Yamazaki, H
Fujieda, M
Togashi, M
Saito, T
Preti, G
Cashman, JR
Kamataki, T
机构
[1] Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Drug Metab, Kita Ku, Sapporo, Hokkaido 0600812, Japan
[2] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA
[4] Human BioMol Res Inst, San Diego, CA 92121 USA
关键词
trimethylamine; trimethylamine N-oxide; fish-like odor syndrome; trimethylaminuria; charcoal; chopper chlorophyllin; flavin-containing monooxygenease; Japanese;
D O I
10.1016/j.lfs.2003.10.022
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
Trimethylaminuria (TMAU) is a metabolic disorder characterized by the inability to oxidize and convert dietary-derived trimethylamine (TMA) to trimethylamine N-oxide (TMAO). This disorder has been relatively well-documented in European and North American populations, but no reports have appeared regarding patients in Japan. We identified seven Japanese individuals that showed a low metabolic capacity to convert TMA to its odorless metabolite, TMAO. The metabolic capacity, as defined by the concentration of TMAO excreted in the urine divided by TMA concentration plus TMAO concentration, in these seven individuals ranged from 70 to 90%. In contrast, there were no healthy controls examined with less than 95% of the metabolic capacity to convert TMA to TMAO. The intake of dietary charcoal (total 1.5 g charcoal per day for 10 days) reduced the urinary free TMA concentration and increased the concentration of TMAO to normal values during charcoal administration. Copper chlorophyllin (total 180 mg per day for 3 weeks) was also effective at reducing free urinary TMA concentration and increasing TMAO to those of concentrations present in normal individuals. In the TMAU subjects examined, the effects of copper chlorophyllin appeared to last longer (i.e., several weeks) than those observed for activated charcoal. The results suggest that the daily intake of charcoal and/or copper chlorophyllin may be of significant use in improving the quality of life of individuals suffering from TMAU. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:2739 / 2747
页数:9
相关论文
共 27 条
[1]
Trimethylaminuria is caused by mutations of the FMO3 gene in a North American cohort [J].
Akerman, BR ;
Lemass, H ;
Chow, LML ;
Lambert, DM ;
Greenberg, C ;
Bibeau, C ;
Mamer, OA ;
Treacy, EP .
MOLECULAR GENETICS AND METABOLISM, 1999, 68 (01) :24-31
[2]
ALWAIZ M, 1987, LANCET, V1, P634
[3]
THE FISH ODOR SYNDROME - BIOCHEMICAL, FAMILIAL, AND CLINICAL ASPECTS [J].
AYESH, R ;
MITCHELL, SC ;
ZHANG, A ;
SMITH, RL .
BRITISH MEDICAL JOURNAL, 1993, 307 (6905) :655-657
[4]
Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism [J].
Cashman, JR .
PHARMACOGENOMICS, 2002, 3 (03) :325-339
[5]
Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria [J].
Cashman, JR ;
Camp, K ;
Fakharzadeh, SS ;
Fennessey, PV ;
Hines, RN ;
Mamer, OA ;
Mitchell, SC ;
Preti, G ;
Schlenk, D ;
Smith, RL ;
Tjoa, SS ;
Williams, DE ;
Yannicelli, S .
CURRENT DRUG METABOLISM, 2003, 4 (02) :151-170
[6]
Interindividual differences of human flavin-containing monooxygenase 3: Genetic polymorphisms and functional variation [J].
Cashman, JR ;
Zhang, J .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (10) :1043-1052
[7]
In vitro and in vivo inhibition of human flavin-containing monooxygenase form 3 (FMO3) in the presence of dietary indoles [J].
Cashman, JR ;
Xiong, Y ;
Lin, J ;
Verhagen, H ;
van Poppel, G ;
van Bladeren, PJ ;
Larsen-Su, S ;
Williams, DE .
BIOCHEMICAL PHARMACOLOGY, 1999, 58 (06) :1047-1055
[8]
Dashwood R, 1996, ENVIRON MOL MUTAGEN, V27, P211, DOI 10.1002/(SICI)1098-2280(1996)27:3<211::AID-EM6>3.0.CO
[9]
2-H
[10]
Fujieda Masaki, 2003, Drug Metab Pharmacokinet, V18, P333, DOI 10.2133/dmpk.18.333